首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1673881

抗毒素市場：按抗毒素類型、依產品類型、依最終用戶、按地區

Anti Venom Market, By Anti-venom Type, By Product Type, By End User, By Geography

出版日期: 2025年02月13日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球抗毒素市場規模為 13.82 億美元，到 2032 年將達到 24.957 億美元，2025 年至 2032 年的複合年成長率為 8.8%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	13.82億美元
效能資料	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	8.80%	2032年價值預測	24.957億美元

數字。 2025年抗毒素市場區域佔有率（%）

全球抗蛇毒血清市場的成長是由於世界熱帶和亞熱帶地區蛇咬和蝎子螫傷發生率的上升所致。每年有超過500萬人被蛇咬傷，其中約270萬人中毒，約10萬人死亡。有效驅蟲劑的出現提高了許多國家蛇咬傷患者的存活率和康復率，增加了對驅蟲劑的需求。領先的製造商正致力於利用最先進的免疫學和生化技術，透過生產技術創新來開發新型抗蛇毒血清。增加投資以提高人們對及時治療和抗蛇毒血清可用性的認知也可能推動市場成長。

市場動態：

全球抗蛇毒血清市場的成長主要受到全球蛇咬和蝎子螫傷發生率不斷增加的推動。根據世界衛生組織統計，每年約有540萬人被蛇咬傷，270萬人被蜇傷，13.7萬人死亡。市場相關人員和政府正在增加投資，以教育農村居民，改善醫療設施的可近性，並確保偏遠地區能夠獲得抗蛇毒血清。但抗蛇毒血清價格昂貴，且保存期限短，儲存和運輸需要限制和管理，限制了其廣泛使用。缺乏認知、傳統信仰和地理障礙限制了開發中國家的受害者獲得及時治療。研究和生產創新、更有效、更實惠的抗蛇毒血清的市場相關人員可以為市場成長提供機會。

本研究的主要特點

本報告對全球抗毒素市場進行了詳細分析，並以 2022 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數概述了全球抗毒素市場的主要企業。
本報告的見解可以幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球抗蛇毒血清市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球抗蛇毒血清市場的各種策略矩陣來促進決策。

公司簡介
- Pfizer, Inc.
- Merck &Co., Inc.
- Sanofi Pasteur
- 4CSL Limited
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Instituto Bioclon SA de CV
- Rare Disease Therapeutics, Inc.
- Vins Bioproducts Limited
- Bharat Serums and Vaccines Limited
- Serum Institute of India Pvt. Ltd.
- Incepta Pharmaceuticals Ltd.
- MicroPharm Limited
- Laboratorios Silanes SA
- BTG plc
- Vacsera
- Indian Immunologicals Limited
- AfrIPI（African Institute of Biomedical Science and Technology）

第 10 章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1249

Global Anti Venom Market is estimated to be valued at USD 1,382.0 Mn in 2025 and is expected to reach USD 2,495.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 1,382.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.80%	2032 Value Projection:	USD 2,495.7 Mn

Figure. Anti Venom Market Share (%), By Region 2025

Global anti venom market growth is driven by rising incidence of snake bites and scorpion stings across tropical and sub-tropical regions of the world. Each year over 5 million people are bitten by snakes, out of which, around 2.7 million cases result in envenoming and around 100,000 deaths. There has been rising demand for anti-venom as the availability of effective anti-venoms has improved survival and recovery rates for victims of snake bites in many countries. Leading manufacturers are engaging in development of novel anti-venoms through reforms in production techniques using modern immunological and biochemical methods. Rising investments towards building awareness about timely treatment and availability of anti-venoms can also drive the market growth.

Market Dynamics:

Global anti venom market growth is primarily driven by increasing incidence of snake bites and scorpion stings globally. According to the World Health Organization, around 5.4 million people suffer from snake bites each year and about 2.7 million are envenomed with around 137,000 deaths. Rising investments by market players and governments towards educating rural populations, improving access to healthcare facilities and ensuring availability of anti-venoms across remote areas can offer lucrative opportunities. However, high costs of anti-venoms, short shelf-life requiring constrained and controlled storage and transportation can limit its widespread adoption. Lack of awareness, traditional beliefs and geographical barriers restrict timely treatment seeking for victims in developing nations. Market players involved in research and production of innovative, more effective and affordable anti-venoms can offer market growth opportunities.

Key features of the study:

This report provides in-depth analysis of the global anti venom market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global anti venom market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bharat Serums & Vaccines, Haffkine Bio-Pharmaceutical Corporation, Vins Bioproducts, Bharat Biotech, and Serum Institute of India
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global anti venom market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti venom market

Detailed Segmentation-

By Anti-venom Type
- Polyvalent
- Monovalent
By Product Type
- Snake Antivenom
- Scorpion Anti-venom
- Spider Anti-venom
- Others
By End User
- Hospitals & clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer, Inc.
- Merck & Co., Inc.
- Sanofi Pasteur
- 4CSL Limited
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Instituto Bioclon S.A. de C.V.
- Rare Disease Therapeutics, Inc.
- Vins Bioproducts Limited
- Bharat Serums and Vaccines Limited
- Serum Institute of India Pvt. Ltd.
- Incepta Pharmaceuticals Ltd.
- MicroPharm Limited
- Laboratorios Silanes S.A.
- BTG plc
- Vacsera
- Indian Immunologicals Limited
- AfrIPI (African Institute of Biomedical Science and Technology)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Anti-venom Type
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Anti Venom Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Anti Venom Market, By Anti-venom Type, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Polyvalent
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Monovalent
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Anti Venom Market, By Product Type, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Snake Antivenom
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Scorpion Anti-venom
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Spider Anti-venom
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Anti Venom Market, By End User, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Anti Venom Market, By Region, 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Pfizer, Inc.
  - Company Highlights
  - Anti-venom Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Anti-venom Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi Pasteur
  - Company Highlights
  - Anti-venom Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- 4CSL Limited
  - Company Highlights
  - Anti-venom Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Haffkine Bio-Pharmaceutical Corporation Ltd.
  - Company Highlights
  - Anti-venom Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Instituto Bioclon S.A. de C.V.
  - Company Highlights
  - Anti-venom Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Rare Disease Therapeutics, Inc.
  - Company Highlights
  - Anti-venom Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vins Bioproducts Limited
  - Company Highlights
  - Anti-venom Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bharat Serums and Vaccines Limited
  - Company Highlights
  - Anti-venom Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Serum Institute of India Pvt. Ltd.
- Incepta Pharmaceuticals Ltd.
- MicroPharm Limited
- Laboratorios Silanes S.A.
- BTG plc
- Vacsera
- Indian Immunologicals Limited
- AfrIPI (African Institute of Biomedical Science and Technology)